5. Private companies

RB can host private companies in 5 laboratories (470 m2).

Each company has an independent 100 m2 space with a secure access comprising a 60 m2 conventional laboratory, a 20 m2 TL2 culture room, and offices.


These private companies have access to the common technical platforms and meeting rooms. IRB hosts in priority companies that will translate to therapeutic use the processes set up in IRB and patented by Montpellier CHU and its partners. These companies will get the large funding necessary to develop therapeutic trials

The companies can also have access to the unit of Cellular and Gene Therapy (870 m2) comprising a P3 laboratory for therapeutic use and 9 class 10000 clean laboratories (375 m2), as well as a large cryogenics room. This Cellular and Gene Therapy Unit has the devices for cell purification and transformation for therapeutic use and is agreed by the French drug agency. The companies will also benefit from the Center for Clinical Investigation, and the CHU and region biology and clinical departments.



Click to see full size picture